Position
Compound Planning, Inc. in Thermo Fisher Scientific Inc.
Back to the book · All holders of TMO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$458.2K$579.49 → $491.61
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 11.1K | $6.41M | — | — | — | 0.2% |
| Q1 2026 | 5.21K | $2.56M | $491.61 | −$458.2K | −$3.39M | 0.1% |